Global Health Tech Unicorns

A unicorn startup or unicorn company is a private company with a valuation over $1 billion USD. Unicorns are ‘startups’, i.e they do not include post-exit, acquired or listed companies, nor do they include ‘mature’ incumbents.

As of 1 February 2023, there are 140 HealthTech Unicorns around the world who are now collectively valued at $320B+

Changes to the above list, older than 12 months are published below.

‍Pristyn Care and Cadence Solutions joined the list in Dec 2021.

‍EQRx left the list in Dec 2021 via IPO.

‍Pear Therapeutics was acquired by Thimble Point (SPAC) in Dec 2021.

‍Abogen, SWORD Health, Curefit and Papa joined the list in Nov 2021.

‍Elemy, Dental Monitoring, and Truepill joined the list in Oct 2021.

‍VillageMD was acquired by Walgreens Boots Alliance in Oct 2021.

‍Babylon Health and Oxford Nanopore Technologies left the list in Oct 2021 via IPO.

‍Spring Health, Mammoth Biosciences and TrialSpark joined the list in Sep 2021.

‍Ginkgo BioWorks left the list in Sep 2021 via IPO.

‍Maven Clinic joined the list in Aug 2021.

‍Grail was acquired by Illumina in Aug 2021.

‍Rani Therapeutics, Lyell Immunopharma and Brii Biosciences left the list in Jul 2021 via IPO.

‍PharmEasy, Prime Medicine, Cerebral, SonderMind, Carbon Health, Yaoshibang and dMed Biopharmaceutical joined the list in Jun – Jul 2021.

‍ATAI Life Sciences and Bright Health left the list in Jun 2021 via IPO.

‍Roivant Sciences left the list in May 2021 via IPO.

‍Capsule, KRY, Caris Life Sciences, Collective Health, Noom, Valgen Medtech, Fiture joined the list in Apr – May 2021.

‍Outcome Health was acquired by PatientPoint in Mar 2021.

‍Aledade, EQRx, Innovaccer, ATAI Life Sciences, Brii BioSciences, Evidation Health, Ginger, Komodo Health, Radiology Partners, Rightway, Unite Us, DispatchHealth, Pear Therapeutics, Insitro and Shulan Health joined the list in Jan – Mar 2021.

‍Recursion Pharmaceuticals left the list in Apr 2021 via IPO.

‍Oscar Health left the list in Mar 2021 via IPO.

‍Sema4 was acquired by Casdin Capital and Corvex Management (SPAC) in Feb 2021.

‍23andMe was acquired by Virgin Galactic Acquisition Corporation (SPAC) in Feb 2021.

‍Clover Health left the list in Jan 2021 via IPO.

🇺🇲 Komodo raised a further $200M in a venture round in December 2022.

🇺🇲 Maven Clinic ($90M) and DispatchHealth ($330M) both went through Series E rounds in November 2022. 

🇺🇲 Saliogen Therapeutics raised $115M in a Series B round in November 2022. 

🇺🇲 Transcarent’s Series C round generated $200M in November 2022 while Athelas ($132M), Athletic Greens ($115M) and Tempus ($100M) all had successful venture rounds in the same month. 

🇺🇲 Orna Therapeutics raised $221M in a Series B in August 2022 with Nimble RX ($14.7M venture round), Owkin ($80M Series B), Resilience ($625M Series D) and BostonGene ($150M Series B) all raised capital in the US market in June 2022.

🇸🇬 Biofourmis raised $300M in a Series D round in April 2022. 

🇺🇲 Nexhealth raised $125M in a Series C round in April 2022 with Reify Health also raising $220M in a Series D in the same month.

🇫🇮 Oura raised capital in April 2022 in an undisclosed series. 

🇺🇲 Clarify Health raised $150M in a Series D round in April 2022. 

🇺🇲 IntelyCare ($115M) and Tessera Therapeutics ($300M) both underwent Series C rounds in April 2022 with Alzheon also raised $50M in a Series D. 

🇺🇲 ConcertAI raised $150M in a Series C in March 2022.

🇫🇷 Doctolib raised $549M in a Series F in March 2022. 

🇺🇲 Somatus ($325M) and Omada Health ($192M) both underwent Series E rounds in February 2022, with Ro ($150M) and Kallyope ($236M) both raising Series D rounds the same month. 

🇺🇲 HealthCare.com raised $31M as a Series C round in February 2022.

🇨🇱 Betterfly raised $125M as a Series C found in February 2022.   

🇺🇲 Alto Pharmacy ($200M Series E), Lyra Health ($235M Series F), Wheel Health ($150M Series C), Commure ($154M Series D) and Freenome ($290M) all raised capital in US market in January 2022.

🇨🇳 Hui Sheng Bio-Pharmaceutical raised $85M as a Series A round in January 2022.

🇺🇲 Eikon Therapeutics raised $518M as a Series B round in January 2022. 

🇫🇷 Alan raised $196M in a Series E round in January 2022. 

🇺🇲 Incredible Health raised $80M in a Series B round in January 2022. 

🇺🇲 Clipboard Health ($30M Series C), Synthego ($200M Series E) and Viz.ai (Series D) all raised capital in US market in January 2022. 

🇨🇳 Xuanzhu Pharma raised $100M in a Series B round in January 2022.

🇺🇲 Bellabeat raised capital in a Series C round in January 2022. 

🇨🇳 CareBridge raised $140M in a venture round in January 2022.

🇨🇭Mindmaze ($105M) and Modernizing Medicine ($53.4M) raised capital in venture rounds in January 2022.

🇨🇳 Tebra raised $72M as a Series B in January 2022.‍